<p>Acute leukaemias; Lymphoma; Multiple myeloma; Solid tumours:</p>

<ul>
	<li>As a single agent: 60-90 mg/m2&nbsp;3-4 wkly.</li>
	<li>Max (total cumulative dose): 0.9-1 g/m2.</li>
	<li>Palliative care: 12.5-25 mg/m2&nbsp;once wkly.</li>
</ul>

<p>Adjuvant treatment in axillary-node positive breast cancer: Recommended starting doses: 100-120 mg/m2&nbsp;as a single dose on day 1 or as 2 divided doses on days 1 and 8 of each 28-day cycle. Repeat for 6 cycles.<br />
<br />
Intravesical Local treatment of bladder carcinoma: As 0.1% soln: 50 mg/wk for 8 wk; reduce dose if chemical cystitis develops.<br />
<br />
For carcinoma in-situ: 80 mg in 50 mL wkly.<br />
<br />
For prevention of recurrence in patients who have undergone transurethral resection: 50 mg/wk for 4 wk, followed by 50 mg/mth for 11 mth; retain soln in the bladder for 1 hr during each administration.</p>

<p><a href="https://medex.com.bd/news/104/danger-of-taking-medication-without-doctors-advice" target="_blank"><em>* চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন</em></a>&#39;</p>